Insilico Medicine partners with Inimmune to advance immunotherapeutic discovery
Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced that the company has achieved a groundbreaking collaboration with Inimmune, which will utilize Chemistry42, Insilico's proprietary generative artificial intelligence (AI) technology to accelerate the discovery and development of next-generation immunotherapeutics.
Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced that the company has achieved a groundbreaking collaboration with Inimmune, which will utilize Chemistry42, Insilico... [5955 chars]
Published by: News-Medical.net
Read full article here: https://www.news-medical.net/news/20240905/Insilico-Medicine-partners-with-Inimmune-to-advance-immunotherapeutic-discovery.aspx
